Newsroom
Sorted by: Latest
-
MarketAxess Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MarketAxess Holdings Inc. - MKTX
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of MarketAxess Holdings Inc. (NasdaqGS: MKTX) to Intercontinental Exchange, Inc. (NYSE: ICE). Under the terms of the proposed transaction, shareholders of MarketAxess will receive $167.00 in cash for each share of MarketAxess that they own. KSF is seeking to determine whether this consideration and the...
-
Golub Capital BDC, Inc. Announces Fiscal Year 2026 Third Quarter Financial Results
NEW YORK--(BUSINESS WIRE)--Golub Capital BDC, Inc., a business development company (Nasdaq: GBDC), today announced its financial results for its third fiscal quarter ended June 30, 2026. Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “Company” refer to Golub Capital BDC, Inc. and its consolidated subsidiaries. “GC Advisors” refers to GC Advisors LLC, our investment adviser. SELECTED FINANCIAL HIGHLIGHTS (in thousands, except per share data) J...
-
Ibotta Reports Second Quarter 2026 Financial Results
DENVER--(BUSINESS WIRE)--Ibotta Reports Second Quarter 2026 Financial Results...
-
The Buying Engine Is Back On: Offerpad Announces Q2 2026 Results With Multi-Year High Margins and Accelerating Signings
TEMPE, Ariz.--(BUSINESS WIRE)--The Buying Engine Is Back On: Offerpad Announces Q2 2026 Results...
-
Custom Truck One Source, Inc. Reports Second Quarter 2026 Results and Increases Full Year 2026 Revenue and Adjusted EBITDA Guidance
KANSAS CITY, Mo.--(BUSINESS WIRE)--Custom Truck One Source, Inc. (NYSE: CTOS), a leading provider of specialty equipment to the electric utility, telecom, rail, forestry, waste management and other infrastructure-related end markets, today reported financial results for the three and six months ended June 30, 2026. CTOS Second-Quarter Highlights Record second quarter revenue of $563.4 million, an increase of $52.0 million, or 10.2%, compared to the second quarter of 2025 Increased Average OEC o...
-
Snap Inc. Announces Second Quarter 2026 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--Snap Inc. (NYSE: SNAP) today announced financial results for the quarter ended June 30, 2026. “Q2 reflects the progress we are making to strengthen our core business and build a more durable financial foundation for Snap,” said Evan Spiegel, co-founder and CEO. “We grew revenue by 19%, expanded margins, and generated positive free cash flow while improving advertising performance and rapidly growing our direct revenue business. We remain focused on serving...
-
BWX Technologies Reports Second Quarter 2026 Results
LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1. “We had strong second quarter 2026 results that were ahead of our expectations,” said Rex. D. Geveden, president and chief executive officer. “Once again we saw strong execution across our business, high growth in Commercial Operations, and good free cash flow generation.” “Demand for new n...
-
Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that the U.S. Food and Drug Administration (FDA) has approved a rituximab biosimilar developed by Dr. Reddy's Laboratories (DRL), a biosimilar to Rituxan®* (rituximab).1 Under an exclusive commercialization agreement, Fresenius Kabi holds exclusive rights to commercialize the biosimilar in the United States. The product was developed, manufactured, and submitted for approval by Dr. Reddy's...
-
Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08
BETHESDA, Md.--(BUSINESS WIRE)--Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced that it issued inducement awards to three new executive officers. Effective August 3, 2026, in connection with commencing employment with Chiron, and as a material inducement to their acceptance of employment with the Company, Aaron Roseth, Chief Operating Officer, Robert H. Zeiller, Chief Development Officer and Head of Seniors Housing, and Matthew Whitlock, Chief Investment Officer...
-
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v...